Neuropathic pain models in the development of analgesic drugs

Scandinavian Journal of Pain

Volumn 2, Issue 4, 2011, Pages 172-177

  Honoré, Per Hartvig ^a   Basnet, Anna ^a   Eljaja, Laila ^a   Kristensen, Pernille ^a   Andersen, Lene Munkholm ^a   Neustrup, Signe ^a   Møllgaard, Pia ^a   Bjerrum, Ole J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Animal models; Neuropathic pain; Spared nerve injury model; Spinal nerve ligation model; Spinal nerve transection model

Indexed keywords

AMINO ACID RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYTOKINE RECEPTOR ANTAGONIST; NARCOTIC ANALGESIC AGENT; NEUROTROPHIN; PROSTAGLANDIN INHIBITOR; SODIUM CHANNEL BLOCKING AGENT;

ALLODYNIA; CHRONIC CONSTRICTION INJURY; DRUG EFFECT; HYPERALGESIA; HYPOALGESIA; NERVE DEGENERATION; NERVE INJURY; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PARTIAL SCIATIC NERVE INJURY; PRIORITY JOURNAL; REVIEW; SAPHENOUS NERVE; SPARED NERVE INJURY; SPINAL GANGLION; SPINAL NERVE LIGATION; SPINAL NERVE TRANSECTION;

EID: 80053138538     PISSN: 18778860     EISSN: 18778879     Source Type: Journal    
DOI: 10.1016/j.sjpain.2011.06.003     Document Type: Review

References (33)

1. Treede R.D., Jensen T.S., Campbell J.N., Cruccu G., Dostrovsky J.O., Griffin J.W., Hansson P., Hughes R., Nurmikko T., Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70:1630-1635.
2. Jensen T.S., Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 2003, 102:1-8.
3. Baron R. Neuropathic pain: a clinical perspective. Handb Exp Pharmacol 2009, 3-30.
4. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001, 429:23-37.
5. Harty T.P., Dib-Hajj S.D., Tyrrell L., Blackman R., Hisama F.M., Rose J.B., Waxman S.G. Na(V)1.7 mutant A863P in erythromelalgia: effects of altered activation and steady-state inactivation on excitability of nociceptive dorsal root ganglion neurons. J Neurosci 2006, 26:12566-12575.
6. Tegeder I., Costigan M., Griffin R.S., Abele A., Belfer I., Schmidt H., Ehnert C., Nejim J., Marian C., Scholz J., Wu T., Allchorne A., Diatchenko L., Binshtok A.M., Goldman D., Adolph J., Sama S., Atlas S.J., Carlezon W.A., Parsegian A., Lotsch J., Fillingim R.B., Maixner W., Geisslinger G., Max M.B., Woolf C.J. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 2006, 12:1269-1277.
7. Attal N., Cruccu G., Haanpaa M., Hansson P., Jensen T.S., Nurmikko T., Sampaio C., Sindrup S., Wiffen P. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006, 13:1153-1169.
8. Dworkin R.H., O'Connor A.B., Backonja M., Farrar J.T., Finnerup N.B., Jensen T.S., Kalso E.A., Loeser J.D., Miaskowski C., Nurmikko T.J., Portenoy R.K., Rice A.S., Stacey B.R., Treede R.D., Turk D.C., Wallace M.S. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007, 132:237-251.
9. Nozaki-Taguchi N., Chaplan S.R., Higuera E.S., Ajakwe R.C., Yaksh T.L. Vincristine-induced allodynia in the rat. Pain 2001, 93:69-76.
10. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
11. Bridges D., Thompson S.W., Rice A.S. Mechanisms of neuropathic pain. Br J Anaesth 2001, 87:12-26.
12. Wang L.X., Wang Z.J. Animal and cellular models of chronic pain. Adv Drug Deliv Rev 2003, 55:949-965.
13. Hogan Q. Animal pain models. Reg Anesth Pain Med 2002, 27:385-401.
14. Kim K.J., Yoon Y.W., Chung J.M. Comparison of three rodent neuropathic pain models. Exp Brain Res 1997, 113:200-206.
15. Dowdall T., Robinson I., Meert T.F. Comparison of five different rat models of peripheral nerve injury. Pharmacol Biochem Behav 2005, 80:93-108.
16. Decosterd I., Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000, 87:149-158.
17. A receptor agonists in the rat spared nerve injury model of neuropathic pain. Eur J Pharmacol 2005, 516:131-138.
18. Bourquin A.F., Suveges M., Pertin M., Gilliard N., Sardy S., Davison A.C., Spahn D.R., Decosterd I. Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse. Pain 2006, 122:14.
19. Erichsen H.K., Blackburn-Munro G. Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain 2002, 98:151-161.
20. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50:355-363.
21. Gustafsson H., Sandin J. Oral pregabalin reverses cold allodynia in two distinct models of peripheral neuropathic pain. Eur J Pharmacol 2009, 605:103-108.
22. Swett J.E., Torigoe Y., Elie V.R., Bourassa C.M., Miller P.G. Sensory neurons of the rat sciatic nerve. Exp Neurol 1991, 114:82-103.
23. LaBuda C.J., Little P.J. Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat. J Neurosci Methods 2005, 144:175-181.
24. Suzuki T., Ueta K., Tamagaki S., Mashimo T. Antiallodynic and antihyperalgesic effect of milnacipran in mice with spinal nerve ligation. Anesth Analg 2008, 106:1309-1315. table.
25. Honore P., Rogers S.D., Schwei M.J., Salak-Johnson J.L., Luger N.M., Sabino M.C., Clohisy D.R., Mantyh P.W. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000, 98:585-598.
26. Minert A., Gabay E., Dominguez C., Wiesenfeld-Hallin Z., Devor M. Spontaneous pain following spinal nerve injury in mice. Exp Neurol 2007, 206:220-230.
27. Tawfik V.L., Regan M.R., Haenggeli C., Lacroix-Fralish M.L., Nutile-McMenemy N., Perez N., Rothstein J.D., DeLeo J.A. Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection. Neuroscience 2008, 152:1086-1092.
28. Sheen K., Chung J.M. Signs of neuropathic pain depend on signals from injured nerve fibers in a rat model. Brain Res 1993, 610:62-68.
29. Whiteside G.T., Adedoyin A., Leventhal L. Predictive validity of animal pain models?. A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology 2008, 54:767-775.
30. Jarvis M.F., Boyce-Rustay J.M. Neuropathic pain: models and mechanisms. Curr Pharm Des 2009, 15:1711-1716.
31. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990, 43:205-218.
32. Kontinen V., Meert T. Predictive validity of neuropathic pain models in pharmacological studies with behavioral outcome in the rat. Proceedings of the 10th world congress on pain 2011, 489-498. IASP Press, Seattle, WA. J. Dostrovsky, D. Carr, M. Kolzenburg (Eds.).
33. Hole K., Tjolsen A. The tail-flick and formalin tests in rodents: changes in skin temperature as a confounding factor. Pain 1993, 53:247-254.